en

PRODUCT DETAIL

Degarelix Accord 80 mg prášok a rozpúšťadlo na injekčný roztok

Code 4782E
MA number EU/1/23/1753/002
Product Form: plv iol 3x80 mg + 3x4,2 ml solv. (liek.inj.skl.+striek.inj.napl.skl.+3 adapt.+3xihla)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L02 ENDOCRINE THERAPY
L02B HORMONE ANTAGONISTS AND RELATED AGENTS
L02BX Other hormone antagonists and relate agents
L02BX02 Degarelix
Shelf life: 24
Container: glass vial
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 29.09.2023
Validity: 29.09.2028
Safety feature Yes
Data update: 23.10.2023
eu-flag.png sk-flag.png